CD19 and asthma: Compared with vehicle-treated mice with experimental asthma, AAL-R mildly reduced CD4+ T lymphocyte numbers in the MLNs (Figure 6A) and failed to modulate CD19+ B cell and DC numbers in this compartment (Figure 6B-C).